What Is Preimplantation Genetic Testing (PGT)?
Preimplantation genetic testing (PGT) is an advanced laboratory procedure performed as part of an IVF (in vitro fertilization) cycle. PGT allows fertility specialists to screen embryos for specific genetic abnormalities or chromosomal conditions before they are implanted in the uterus. By analyzing the DNA of embryos at a very early stage, preimplantation genetic testing helps identify those with the highest potential for healthy development and further minimizes the risk of passing on certain inheritable diseases.
PGT does not modify or change an embryo’s genes. Instead, it provides important information that guides which embryos are selected for transfer during IVF, helping patients, couples, and fertility teams make informed decisions about family building. The main goals of PGT are to increase the chances of a successful pregnancy, reduce miscarriage risk, and decrease the likelihood of certain genetic or chromosomal conditions in the offspring.
Key Point: PGT is a screening technique, not a gene editing tool—it does not alter an embryo’s DNA, only informs selection prior to implantation.
Key Takeaways
- Preimplantation genetic testing (PGT) screens embryos for genetic or chromosomal abnormalities before transfer in an IVF cycle.
- PGT encompasses multiple forms: PGT-A (for chromosome number), PGT-M (for specific gene conditions), and PGT-SR (for chromosomal rearrangements).
- The primary aim is to identify embryos with a better chance of healthy pregnancy and to reduce inherited genetic disorders.
- PGT is particularly useful for those with a history of genetic disease, recurrent pregnancy loss, repeated IVF failures, or advanced maternal age.
- While highly accurate, PGT does not guarantee a pregnancy or the birth of a healthy child.
- Adding PGT increases IVF’s cost and complexity and involves important ethical discussions.
- PGT requires collaborative care between fertility doctors, embryologists, and genetic counselors.
- Not all genetic diseases or conditions can be detected by PGT—current techniques have limitations.
- Decisions around PGT should be made with personalized medical and genetic counseling.
- Insurance reimbursement for PGT varies and is not always available.
Table of Contents
- What Is Preimplantation Genetic Testing (PGT)?
- What Types of PGT Exist and What Do They Screen For?
- How Does the Preimplantation Genetic Testing Process Work?
- Who Should Consider PGT During IVF?
- What Are the Benefits of Preimplantation Genetic Testing?
- What Are the Limitations and Risks of PGT?
- Step-by-Step: The PGT Process in IVF
- Ethical Considerations and Social Implications of PGT
- What Does PGT Cost? Is It Covered by Insurance?
- Frequently Asked Questions About Preimplantation Genetic Testing
- Lifestyle and Preparation Tips for Those Considering PGT
- References and Further Reading
- Disclaimer
What Types of PGT Exist and What Do They Screen For?
Preimplantation genetic testing includes several subtypes, each targeting different categories of genetic issues that may affect an embryo. Understanding these distinct forms can help individuals and couples clarify whether PGT is appropriate for their circumstances and what can be detected before pregnancy.
PGT-A: Preimplantation Genetic Testing for Aneuploidy
- Purpose: Screens for aneuploidy—an abnormal number of chromosomes in the embryo. Common chromosomal abnormalities include Down syndrome (trisomy 21), Turner syndrome (monosomy X), and Edwards syndrome (trisomy 18).
- Context: Chromosome number errors (aneuploidies) are the leading cause of miscarriage, IVF failure, and certain birth defects.
- Use: Especially common for women of advanced maternal age, repeated IVF failure, or recurrent miscarriages.
PGT-M: Preimplantation Genetic Testing for Monogenic Diseases
- Purpose: Identifies embryos with single-gene (monogenic) disorders such as cystic fibrosis, Tay-Sachs disease, thalassemia, or sickle cell anemia.
- Context: Used when either or both parents carry a known gene mutation for a specific inherited condition.
- Use: Reduces the chances of a child inheriting a particular genetic disease.
PGT-SR: Preimplantation Genetic Testing for Structural Rearrangements
- Purpose: Detects structural changes in chromosomes including inversions and translocations (reciprocal or Robertsonian translocations).
- Context: These rearrangements may not change the amount of genetic material but can disrupt gene function or cause embryos to have unbalanced chromosomes.
- Use: Benefits parents who are carriers of chromosomal rearrangements, helping to select embryos with a balanced chromosomal structure.
Quick Facts Table: Types of PGT
| Type | What It Screens For | Best For | Example Disorders Detected |
|---|---|---|---|
| PGT-A | Chromosome number abnormalities (aneuploidy) | Women of advanced maternal age, repeated IVF failure | Down syndrome, Turner syndrome, trisomy 18 |
| PGT-M | Single-gene (monogenic) disorders | Couples with known family genetic risks | Cystic fibrosis, Tay-Sachs, thalassemia |
| PGT-SR | Chromosomal structural rearrangements | Carriers of balanced chromosomal rearrangement | Infertility due to translocations |
Did you know? The terms PGD (preimplantation genetic diagnosis) and PGS (preimplantation genetic screening) have largely been replaced by the terms PGT-M and PGT-A, to improve clarity and precision.
How Does the Preimplantation Genetic Testing Process Work?
PGT is fully integrated into a standard IVF cycle, adding steps specifically for genetic screening. The typical process involves:
- Ovarian Stimulation: Fertility medications are used to promote development of multiple eggs in the ovaries.
- Egg Retrieval: Mature eggs are collected via a brief outpatient procedure, usually under sedation.
- Fertilization: Eggs are fertilized with sperm, either by traditional IVF or by intracytoplasmic sperm injection (ICSI).
- Embryo Culture: Embryos are cultured in the laboratory, often reaching the blastocyst stage (typically 5 or 6 days after fertilization).
- Embryo Biopsy: Several cells are gently removed from each blastocyst. These cells typically form the outer layer (trophectoderm), destined to become the placenta—not the fetus.
- Genetic Analysis: The biopsied cells are analyzed in a specialized genetics laboratory to detect chromosomal or gene abnormalities relevant to the family’s risk factors.
- Embryo Selection and Transfer: Embryologists and physicians use the results to select embryos without detected abnormalities for transfer. Remaining embryos may be frozen for later use.
PGT Process Flow
Ovarian Stimulation → Egg Retrieval → Fertilization → Embryo Culture → Biopsy → Genetic Analysis → Embryo Selection → Transfer
Key Point: Biopsying the trophectoderm—rather than the inner cell mass—minimizes potential impact on future fetal development.
Who Should Consider PGT During IVF?
PGT is not recommended for everyone undergoing IVF but can be particularly valuable for certain groups:
Indications for PGT
- Advanced Maternal Age ([typically ≥35 years]): As women age, the risk of chromosomal abnormalities in eggs increases.
- Recurrent Pregnancy Loss: Repeated miscarriages may be due to unrecognized genetic issues in embryos.
- Prior IVF Failure: Multiple failed embryo transfers may reflect underlying embryo genetic issues.
- Parental Carriers of Genetic Disorders: Families with a personal or family history of inheritable genetic diseases (e.g., cystic fibrosis, Tay-Sachs) can reduce the risk of transmission.
- Carriers of Chromosomal Rearrangements: Parents with balanced translocations or inversions can proactively select chromosomally normal embryos.
- Avoidance of Sex-Linked Diseases: In medically indicated cases, PGT can help prevent X- or Y-linked inherited diseases.
Typical Candidates Table
| Situation | How PGT May Help |
|---|---|
| Woman age >35 | Screens for embryo aneuploidy (chromosome number) |
| Recurrent unexplained miscarriages | Detects chromosomal imbalances causing pregnancy loss |
| Family history of inherited disease | Screens out embryos with known gene mutations |
| Previous failed IVF cycles | Identifies previously undetected embryo genetic issues |
| Balanced chromosomal rearrangement | Selects embryos with normal chromosomal structures |
| Sex-linked disorder risk | Permits selection by sex where permitted |
Scenario Example: A couple has experienced multiple miscarriages and genetic counseling reveals a balanced translocation in one partner. PGT-SR is recommended during IVF to identify embryos without unbalanced chromosomes for transfer, increasing the likelihood of a successful pregnancy.
What Are the Benefits of Preimplantation Genetic Testing?
Used appropriately, PGT may offer several clinically significant and emotionally reassuring advantages.
1. Potentially Higher IVF Success Rates
Selecting embryos with normal chromosomes may improve implantation rates and live-birth outcomes, particularly in women of advanced age or with recurrent IVF failure [Forman EJ, et al.].
2. Reduced Risk of Genetic Disorders
PGT makes it possible to avoid transferring embryos with mutations for known single-gene conditions or with major chromosomal abnormalities [Cinnioglu C, et al.].
3. Lower Risk of Miscarriage
As chromosomal errors are a key cause of early pregnancy losses, transferring euploid (chromosomally normal) embryos may decrease miscarriage rates.
4. Informed Decision-Making
PGT provides clear genetic information to guide family planning, supporting informed and proactive decisions.
5. Ethical Family Balancing (in permitted settings)
PGT can be used to avoid transmission of serious X- or Y-linked diseases through selection by genetic sex (subject to regulatory guidelines).
Myths vs. Facts Table
| Myth | Fact |
|---|---|
| PGT guarantees a healthy baby | PGT reduces some genetic risks but cannot guarantee overall child health |
| PGT is unsafe for embryos | When performed by experts, embryo biopsy at blastocyst stage is very safe |
| PGT detects all health problems | PGT is targeted: it only screens for specific, predefined genetic conditions |
| PGT is helpful only for women with fertility issues | PGT is beneficial for families with male or female genetic risks |
What Are the Limitations and Risks of PGT?
Despite its clinical value, PGT involves certain limitations and potential drawbacks that ought to be carefully considered.
1. No Guarantee of Pregnancy or Health
Many factors affect IVF outcomes—PGT reduces (but does not eliminate) risk of inherited disorders but cannot ensure a successful pregnancy or overall baby health [Gleicher N, et al.].
2. Possibility of False Positive or Negative Results
- Mosaicism: Embryos can contain both normal and abnormal cells, occasionally causing misdiagnosis [Minasi MG, et al.].
- Technical Limitations: Rare errors can occur due to biopsy technique or lab processing.
3. Emotional and Ethical Complexity
PGT may raise challenging ethical dilemmas or emotional distress regarding embryo selection, especially for conditions with variable or uncertain outcomes.
4. High Cost and Limited Accessibility
PGT adds significant cost to IVF cycles and may not be fully covered by insurance, potentially limiting access for some individuals or couples.
5. Small Risk of Embryo Damage
Though very low, there is a small risk an embryo is compromised during biopsy.
Risks and Harm Reduction Table
| Potential Risk | Ways to Minimize Risk |
|---|---|
| False positive/negative | Use experienced labs and repeat testing if suspect |
| Embryo biopsy harm | Employ expert embryologists, biopsy at blastocyst stage |
| Emotional distress | Seek genetic counseling pre- and post-testing |
| Financial burden | Discuss coverage and payment plans in advance |
Did you know? Current technology cannot detect all possible genetic or developmental problems. Some disorders cannot be screened at this stage [Harper JC, et al.].
Step-by-Step: The PGT Process in IVF
A clear understanding of the IVF and PGT workflow can help reduce patient stress and support informed decision-making:
- Initial Consultation: Meet with a reproductive endocrinologist and genetic counselor to review personal and family history; determine whether PGT is advised.
- Ovarian Stimulation: Hormonal medications are used to mature multiple eggs, monitored by ultrasound and blood tests.
- Egg Retrieval: Outpatient procedure to collect eggs from the ovaries under sedation.
- Fertilization: Sperm and eggs are combined via IVF or ICSI.
- Embryo Culture: Embryos grown in lab until blastocyst stage (5–6 days).
- Embryo Biopsy: A few cells carefully removed from outer (trophectoderm) layer.
- Genetic Analysis: Biopsied cells tested for genetic/chromosomal issues in a specialized lab.
- Embryo Freezing: Embryos are generally cryopreserved while awaiting test results.
- Embryo Transfer: Chromosomally and genetically normal embryo(s) are thawed and transferred to the uterus.
- Pregnancy Testing: About two weeks after embryo transfer, a blood test determines if pregnancy has occurred.
Callout: The entire process, from consultation through transfer and pregnancy testing, commonly requires two to three months in total.
Ethical Considerations and Social Implications of PGT
PGT’s ability to screen embryos—and, by extension, influence human inheritance—raises significant ethical, legal, and social questions:
Embryo Disposition
Deciding what to do with unused or “abnormal” embryos is a common source of emotional challenge.
Genetic Selection and “Designer Babies”
Public concerns involve the potential for non-medical selection (e.g., traits like eye color or intelligence), which most medical organizations and laws seek to restrict.
Access and Equity
The high cost and variable insurance coverage mean access to PGT is not equally available to all, raising issues of fairness.
Legal and Regulatory Variation
Laws differ widely—some countries limit PGT to specific hereditary disease prevention; others restrict or ban use for non-medical reasons.
Scenario Example: In the UK, PGT is allowed only to prevent serious hereditary disorders or sex-linked diseases—not for selection based on appearance or “family balancing.”
What Does PGT Cost? Is It Covered by Insurance?
Cost is often a key factor for patients considering PGT as part of IVF.
Typical Costs
- PGT Alone: $3,000–$7,000 per IVF cycle, depending on the scope and number of embryos tested.
- Total (IVF plus PGT): $20,000–$25,000 (including all associated procedures and medications).
- Insurance: Some insurance policies may cover PGT for medically indicated reasons, such as known hereditary risks; many do not, or offer only partial coverage.
Financing Options
- Many fertility clinics have payment plans, or relationships with medical financing services.
- Nonprofit organizations and grant programs may provide assistance in certain cases.
Did you know? Asking about costs, insurance eligibility, and payment options early in the process helps reduce financial surprises down the line.
Frequently Asked Questions About Preimplantation Genetic Testing
What does preimplantation genetic testing (PGT) mean in IVF?
PGT means screening embryos created through IVF for specific genetic or chromosomal abnormalities before implantation. It allows only selected embryos—those not carrying detectable inherited risks—to be transferred to the uterus.
Is preimplantation genetic testing (PGT) safe for embryos?
Current evidence suggests that embryo biopsy, when performed by trained professionals at the blastocyst stage, is very safe and has little or no impact on embryo health or pregnancy rates [Brezina PR, et al.]. Rarely, damage to an embryo can occur.
How accurate is PGT?
PGT is generally over 95% accurate for targeted conditions, but accuracy can be reduced by mosaicism (mixed normal and abnormal cells) or sample handling limits [Minasi MG, et al.].
Can PGT detect all genetic diseases?
No, PGT can only screen for the specific genetic issues it is designed for, such as known single-gene disorders, common chromosomal abnormalities, or structural rearrangements. Rare or uncharacterized mutations and many complex traits remain undetectable [Harper JC, et al.].
Who benefits most from PGT?
PGT is especially recommended for couples with a history of genetic disorders, advanced maternal age, repeated miscarriages or failed IVF cycles, or when either parent is a known carrier of a chromosomal rearrangement.
Does PGT guarantee the birth of a healthy baby or pregnancy success?
PGT significantly reduces certain genetic risks but does not guarantee a healthy baby or pregnancy. Other factors, including non-genetic health issues and chance, continue to play a major role.
What is the difference between PGT, PGT-A, PGT-M, and PGT-SR?
- PGT is the umbrella term for all preimplantation embryo genetic testing.
- PGT-A identifies chromosomal aneuploidies (abnormal number).
- PGT-M screens for specific single-gene (monogenic) disorders.
- PGT-SR detects chromosomal structural rearrangements.
Are there emotional or psychological downsides to PGT?
Yes, some people find the process of selecting embryos based on genetics emotionally or ethically challenging. Professional pre- and post-test counseling is strongly recommended.
Is PGT ever used for family balancing or gender selection?
It can be, but in most countries this is permitted only for medical purposes—such as avoiding sex-linked diseases—not simply for personal preference.
What happens if no healthy embryos are identified after PGT?
If all embryos carry a genetic or chromosomal problem, options may include another IVF cycle, considering donor eggs or sperm, using affected embryos (rare and controversial), or exploring other family-building paths.
Is PGT available for single parents or same-sex couples?
Yes, PGT can be included in IVF for singles and couples of any gender—provided embryos are created via IVF.
Can men be the “source” of problems detected by PGT?
Absolutely. Gene mutations and chromosomal rearrangements may arise from the male or female partner.
How many embryos do I need for PGT to be worthwhile?
There is no strict minimum, but retrieving more eggs increases the chance of obtaining at least one healthy, transferable embryo through PGT.
Is PGT covered by insurance?
Coverage is highly variable—ask your provider. Some policies cover PGT for known hereditary risks but not for non-medical or elective uses.
Who performs PGT genetic testing of embryos?
PGT is performed in highly specialized reproductive genetics laboratories, coordinated by fertility clinics and their embryology teams.
Does PGT change the child’s DNA?
No. PGT only screens embryos and informs selection. It does not edit, change, or otherwise impact a child’s genetic makeup.
Are there alternatives to PGT?
Yes—prenatal testing after pregnancy (like amniocentesis or CVS), use of donor eggs or sperm, traditional conception, or adoption. Each has unique considerations.
How long does the PGT process take?
PGT lab analysis usually takes about one to two weeks. Including all IVF steps, an entire cycle often spans two to three months.
When should I consult a doctor or genetic counselor about PGT?
Seek advice if you or your partner have a personal or family history of inherited disorders, are of advanced maternal age, have experienced repeated miscarriage or IVF failure, or have questions about genetic risk.
Lifestyle and Preparation Tips for Those Considering PGT
Beyond laboratory procedures, preparation and general wellness can play a role in optimizing fertility outcomes:
- Optimize Nutrition: Focus on a balanced diet rich in fruits, vegetables, whole grains, and lean protein.
- Avoid Tobacco, Drugs, and Excess Alcohol: These can negatively affect egg and sperm quality.
- Manage Stress: Use mindfulness, counseling, meditation, or support groups during the IVF/PGT process.
- Maintain Regular Physical Activity: Engage in moderate exercise most days, avoiding extreme regimens.
- Prioritize Sleep: Aim for 7–9 hours each night to support hormonal health.
- Limit Caffeine: Keep intake below recommended daily limits.
- Open Communication: Stay in close touch with your fertility team, ask questions, and seek advice on optimizing your unique health profile.
Key Point: Good self-care and proactive communication with your fertility care team can help improve your experience and may contribute to better outcomes.
References and Further Reading
- Forman EJ, et al. "Increased implantation rates after preimplantation genetic screening with aneuploidy screening: a randomized trial." https://pubmed.ncbi.nlm.nih.gov/29411613/
- Cinnioglu C, et al. "Role of preimplantation genetic testing (PGT) in modern reproductive medicine." https://pubmed.ncbi.nlm.nih.gov/31303349/
- Gleicher N, et al. "Preimplantation genetic testing for aneuploidy—who benefits?" https://pubmed.ncbi.nlm.nih.gov/28967110/
- Minasi MG, et al. "Mosaic embryos and preimplantation genetic testing: technical and clinical considerations." https://pubmed.ncbi.nlm.nih.gov/27720622/
- Brezina PR, et al. "Clinical applications of preimplantation genetic diagnosis and screening." https://pubmed.ncbi.nlm.nih.gov/26363901/
- Harper JC, et al. "Preimplantation genetic testing: current status and future prospects." https://pubmed.ncbi.nlm.nih.gov/33714977/
- American Society for Reproductive Medicine (ASRM): https://www.asrm.org/
- Society for Assisted Reproductive Technology (SART): https://www.sart.org/
- Human Fertilisation & Embryology Authority (HFEA): https://www.hfea.gov.uk/
Disclaimer
This article is for informational and educational purposes only and does not constitute medical or mental health advice. It is not a substitute for speaking with a qualified healthcare provider, licensed therapist, or other professional who can consider your individual situation.
